UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lewy Bodies

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (6), p.1661-1668

Shults, Clifford W.

2006

Volltextzugriff (PDF)

Natural history of multiple system atrophy in the USA: a prospective cohort study

Lancet neurology, 2015-07, Vol.14 (7), p.710-719

2015

Volltextzugriff (PDF)

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

Movement disorders, 2004-12, Vol.19 (12), p.1391-1402

2004

Volltextzugriff (PDF)

Clinical trials of coenzyme Q10 in neurological disorders

BioFactors (Oxford), 2005, Vol.25 (1-4), p.117-126

2005

Volltextzugriff (PDF)

Dopamine Depletion Induces Distinct Compensatory Gene Expression Changes in DARPP-32 Signal Transduction Cascades of Striatonigral and Striatopallidal Neurons

The Journal of neuroscience, 2009-05, Vol.29 (21), p.6828-6839

2009

Volltextzugriff (PDF)

Potential outcome measures and trial design issues for multiple system atrophy

Movement disorders, 2007-12, Vol.22 (16), p.2371-2377

2007

Volltextzugriff (PDF)

Intrastriatal Injection of Sonic Hedgehog Reduces Behavioral Impairment in a Rat Model of Parkinson's Disease

Experimental neurology, 2002-01, Vol.173 (1), p.95-104

2002

Volltextzugriff (PDF)

Therapeutic role of coenzyme Q10 in Parkinson's disease

Pharmacology & therapeutics (Oxford), 2005-07, Vol.107 (1), p.120-130

Shults, Clifford W.

2005

Volltextzugriff (PDF)

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

The Lancet (British edition), 2005-01, Vol.365 (9457), p.410-412

2005

Volltextzugriff (PDF)

Coenzyme Q10 in neurodegenerative diseases

Current medicinal chemistry, 2003-10, Vol.10 (19), p.1917-1921

Shults, Clifford W

2003

Volltextzugriff (PDF)

Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters

Journal of neuroscience research, 2002-06, Vol.68 (5), p.568-578

2002

Volltextzugriff (PDF)

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

Experimental neurology, 2004-08, Vol.188 (2), p.491-494

2004

Volltextzugriff (PDF)

Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons

Neurobiology of disease, 2009-04, Vol.34 (1), p.178-188

2009

Volltextzugriff (PDF)

Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP

Experimental neurology, 2004-04, Vol.186 (2), p.158-172

2004

Volltextzugriff (PDF)

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy

The Journal of neuroscience, 2005-11, Vol.25 (46), p.10689-10699

2005

Volltextzugriff (PDF)

The Adult Substantia Nigra Contains Progenitor Cells with Neurogenic Potential

The Journal of neuroscience, 2002-08, Vol.22 (15), p.6639-6649

2002

Volltextzugriff (PDF)

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease

Movement disorders, 2015-05, Vol.30 (6), p.862-866

2015

Volltextzugriff (PDF)

BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine

Neuroreport, 1995-05, Vol.6 (8), p.1109-1112

1995

Volltextzugriff (PDF)

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

Annals of neurology, 1995-06, Vol.37 (6), p.714-722

1995

Volltextzugriff (PDF)

Mitochondrial dysfunction and possible treatments in Parkinson's disease--a review

Mitochondrion, 2004-09, Vol.4 (5-6), p.641-648

Shults, Clifford W

2004

Volltextzugriff (PDF)

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia

Movement disorders, 2006-01, Vol.21 (1), p.45-49

2006

Volltextzugriff (PDF)

Mutations in DJ-1 are rare in familial Parkinson disease

Neuroscience letters, 2006-11, Vol.408 (3), p.209-213

2006

Volltextzugriff (PDF)

Antioxidants as therapy for Parkinson's disease

Antioxidants & redox signaling, 2005-05, Vol.7 (5-6), p.694-700

Shults, Clifford W

2005

Volltextzugriff (PDF)

Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease

BioFactors (Oxford), 2003, Vol.18 (1-4), p.153-161

2003

Volltextzugriff (PDF)

α-Synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy

Neuroscience letters, 2006-09, Vol.405 (3), p.223-225

2006

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(45)
Humans
(41)
Neurosciences & Neurology
(37)
Biological And Medical Sciences
(35)
Animals
(33)
Male
(30)
Female
(29)
Medical Sciences
(27)
Neurosciences
(25)
Rats
(21)
Middle Aged
(20)
Parkinson's Disease
(20)
Neurology
(19)
Aged
(16)
Clinical Neurology
(15)
Parkinson Disease - Drug Therapy
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Ubiquinone - Analogs & Derivatives
(10)
Coenzymes
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lewy Bodies

Natural history of multiple system atrophy in the USA: a prospective cohort study

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

Clinical trials of coenzyme Q10 in neurological disorders

Dopamine Depletion Induces Distinct Compensatory Gene Expression Changes in DARPP-32 Signal Transduction Cascades of Striatonigral and Striatopallidal Neurons

Potential outcome measures and trial design issues for multiple system atrophy

Intrastriatal Injection of Sonic Hedgehog Reduces Behavioral Impairment in a Rat Model of Parkinson's Disease

Therapeutic role of coenzyme Q10 in Parkinson's disease

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

Coenzyme Q10 in neurodegenerative diseases

Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons

Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy

The Adult Substantia Nigra Contains Progenitor Cells with Neurogenic Potential

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease

BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

Mitochondrial dysfunction and possible treatments in Parkinson's disease--a review

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia

Mutations in DJ-1 are rare in familial Parkinson disease

Antioxidants as therapy for Parkinson's disease

Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease

α-Synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy

Suchergebnisse filtern